Carfilzomib versus bortezomib: no longer an ENDEAVOR

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)1288-1290
Number of pages3
JournalThe Lancet Oncology
Volume18
Issue number10
DOIs
Publication statusPublished - 1 Oct 2017

Cite this